Mark E. Saad - 04 Mar 2022 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney in Fact
Issuer symbol
AXSM
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 16:00:15 UTC
Previous filing
19 Nov 2021
Next filing
07 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +2,337 $0.000000 2,337 04 Mar 2022 Common Stock 2,337 $29.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 2,337 options elected to be received in lieu of cash compensation earned in 2021. All of such options are immediately exercisable.